iLoF is working to enable a new era of personalized medicine, using AI and photonics to build a cloud-based library of diseases biomarkers and biological profiles. We process massive amounts of optical and clinical data, providing screening and stratification tools for complex, heterogeneous diseases, in an affordable, fast, portable way.
This allows pharmaceutical companies and biotechs to save up to 40% of cost and 70% of the time spent screening for clinical trials, while at the same time, making the whole process more convenient for patients.
Winning the 4YFN Impact Awards was certainly one of the highlights of this quarter for iLoF: but it was both an honor, and a responsibility. 4YFN brings together in a unique way a mix of innovators, founders, creators and leaders, all with the same goal of shaping the future, and we were delighted to be able to meet or re-connect (finally in person) with many of the stakeholders (investors or partners) we have been working virtually for the last few months. Overall, while it was the first time attending, we will certainly go again, and recommend it to everyone on the scene.